|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.890 USD | +14.25% |
|
+2.30% | +91.02% |
| Market Cap | 291M 43.02M 37.15M 34.24M 32.05M 60.06M 4.09B 60.99M 404M 158M 1.99B 161M 158M 6.89B | P/E Ratio 2024 |
-6.03x | P/E Ratio 2025 | -2.35x |
|---|---|---|---|---|---|
| Enterprise Value | -59.26M -8.76M -7.56M -6.97M -6.52M -12.23M -832M -12.42M -82.29M -32.09M -405M -32.86M -32.16M -1.4B | EV / Sales 2024 |
0.01x | EV / Sales 2025 | -0.02x |
| Free-Float |
39.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +14.25% | ||
| 1 week | +2.30% | ||
| Current month | -7.39% | ||
| 1 month | -19.44% | ||
| 3 months | -24.54% | ||
| 6 months | +35.46% | ||
| Current year | +91.02% |
| 1 week | 4.05 | 5.23 | |
| 1 month | 4.05 | 6.36 | |
| Current year | 2.48 | 11.17 | |
| 1 year | 2.48 | 11.17 | |
| 3 years | 2.48 | 33.6 | |
| 5 years | 2.48 | 101.8 | |
| 10 years | 2.48 | 458.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun Ling Liu
CEO | Chief Executive Officer | 61 | 2013-04-30 |
Yang Chen
DFI | Director of Finance/CFO | 56 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Gang Yu
CHM | Chairman | 66 | 2013-04-30 |
Jun Ling Liu
CHM | Chairman | 61 | 2013-04-30 |
Nee Chuan Teo
BRD | Director/Board Member | 55 | 2018-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.25% | +2.30% | -40.22% | -82.28% | 43.02M | ||
| -0.40% | +1.08% | +7.29% | +98.36% | 94.25B | ||
| +1.22% | +8.82% | +39.45% | +156.77% | 52.43B | ||
| -1.86% | -9.59% | -18.01% | +230.00% | 21.42B | ||
| +0.62% | +0.49% | -11.87% | -26.06% | 8.13B | ||
| -0.07% | +2.43% | -35.41% | -27.86% | 7.54B | ||
| +1.19% | -1.22% | -11.27% | -36.33% | 6.77B | ||
| -2.80% | -2.46% | +9.63% | +20.45% | 6.49B | ||
| +0.30% | +1.01% | -1.34% | +17.66% | 5.32B | ||
| +1.27% | -3.62% | -12.11% | -15.86% | 3.53B | ||
| Average | +1.37% | +1.07% | -7.39% | +33.48% | 20.59B | |
| Weighted average by Cap. | -0.06% | +3.45% | +9.42% | +106.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 14.4B 2.13B 1.84B 1.69B 1.59B 2.97B 202B 3.02B 20B 7.8B 98.46B 7.99B 7.82B 341B | 12.56B 1.86B 1.6B 1.48B 1.38B 2.59B 176B 2.63B 17.44B 6.8B 85.84B 6.96B 6.82B 297B |
| Net income | -64.74M -9.57M -8.26M -7.61M -7.13M -13.36M -909M -13.56M -89.91M -35.06M -443M -35.91M -35.14M -1.53B | -66.39M -9.81M -8.47M -7.81M -7.31M -13.7M -933M -13.91M -92.2M -35.95M -454M -36.82M -36.04M -1.57B |
| Net Debt | -225M -33.3M -28.76M -26.5M -24.81M -46.5M -3.17B -47.22M -313M -122M -1.54B -125M -122M -5.33B | -350M -51.77M -44.72M -41.21M -38.57M -72.29M -4.92B -73.4M -487M -190M -2.4B -194M -190M -8.29B |
Employees
1,063
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 4.890 $ | +14.25% | 63,632 |
| 26-06-11 | 4.280 $ | -1.83% | 47,994 |
| 26-06-10 | 4.360 $ | -0.91% | 25,702 |
| 26-06-09 | 4.400 $ | -7.17% | 10,041 |
| 26-06-08 | 4.740 $ | -0.84% | 15,731 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YI Stock
Select your edition
All financial news and data tailored to specific country editions
















